Liens utiles

Institut National du Cancer agence d'expertise sanitaire et scientifique en cancérologie

Nota Bene Cancer bulletin de veille bibliographique dans les divers domaines de la recherche sur les cancers

Onco Actu brèves sur le web anglophone

 

Tous les liens utiles

Accueil » La R&D d'Unicancer » Les publications de la R&D d'Unicancer » Les publications

Publications de la R&D d'Unicancer

2016

Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial

Lerebours F et al., Cancer. 2016 Oct;122(19):3032-40

2016

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

Péron J et al., Oncotarget. 2016 Dec 13;7(50):82953-82960.

2016

Applying the longitudinal model from item response theory to assess health-related quality of life in the PRODIGE 4/ACCORD 11 randomized trial.

Barbieri A et al., Med Decis Making. 2016 Jul;36(5):615-28.

2016

The ConSoRe project supports the implementation of big data in oncology [article in French]

Heudel P et al., Bull Cancer. 2016 Nov;103(11):949-95

2016

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.

Delaloge S et al., Ann Oncol. 2016 Sep;27(9):1725-32.

2016

Routinely collected data may usefully supplement randomised controlled data on treatment effects for mortality.

Pérol D et al., BMJ 2016;355:i6745

2016

Reply to 'The potential and perils of observational studies' by M. Buyse et al.

Delaloge S et al., Ann Oncol. 2016 Nov 9.

2016

Unicancer ESMÉ Program: how to use real world data to build a new research model in oncology [article in French]

Cailliot C et al., Innovations & Thérapeutiques en Oncologie. 2016;2(4):164-166.

2016

Phase I, Dose-Escalation Trial of Pazopanib in Combination with Cisplatin in Patients with advanced Solid Tumors: A UNICANCER Study.

Diéras V et al., Oncol Ther (2016) 4: 211.

2016

Pharmacokinetic interaction between pazopanib and cisplatin regimen.

Imbs DC et al., Cancer Chemother Pharmacol. 2016 Feb;77(2):385-92.